SEC Form 4 · accession 0001235802-15-000014
UROPLASTY INC · UPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Kill
Officer — President and CEO · Director
Period of report
Jan 29, 2015
Accepted (ET)
Jan 29, 2015 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890846
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2015 | P | 100 | $1.22 | A | 14,050 | I | By Trust |
| Common Stock | Jan 29, 2015 | P | 2,500 | $1.229 | A | 16,550 | I | By Trust |
| Common Stock | Jan 29, 2015 | P | 6,150 | $1.23 | A | 22,700 | I | By Trust |
| Common Stock | Jan 29, 2015 | P | 16,250 | $1.28 | A | 38,950 | I | By Trust |
| Common StockF1 | holding | — | — | — | 486,050 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 140,000 shares that will be issued over time upon vesting pursuant to a restricted stock grant.